Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial

BACKGROUND AND PURPOSE: Although dual antiplatelet therapy (DAPT) with aspirin and clopidogrel reduces the recurrence of ischemic stroke while significantly increasing the bleeding events compared with monotherapy, the CSPS.com trial (Cilostazol Stroke Prevention Study combination) showed that DAPT...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoshino, Haruhiko, Toyoda, Kazunori, Omae, Katsuhiro, Ishida, Noriyuki, Uchiyama, Shinichiro, Kimura, Kazumi, Sakai, Nobuyuki, Okada, Yasushi, Tanaka, Kortaro, Origasa, Hideki, Naritomi, Hiroaki, Houkin, Kiyohiro, Yamaguchi, Keiji, Isobe, Masanori, Minematsu, Kazuo, Matsumoto, Masayasu, Tominaga, Teiji, Tomimoto, Hidekazu, Terayama, Yasuo, Yasuda, Satoshi, Yamaguchi, Takenori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547582/
https://www.ncbi.nlm.nih.gov/pubmed/34404237
http://dx.doi.org/10.1161/STROKEAHA.121.034378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547582/
https://www.ncbi.nlm.nih.gov/pubmed/34404237
http://dx.doi.org/10.1161/STROKEAHA.121.034378

Ejemplares similares